title: Minimally invasive surgery and cancer: controversies part 1.
abstract: Perhaps there is no more important issue in the care of surgical patients than the appropriate use of minimally invasive surgery (MIS) for patients with cancer. Important advances in surgical technique have an impact on early perioperative morbidity, length of hospital stay, pain management, and quality of life issues, as clearly proved with MIS. However, for oncology patients, historically, the most important clinical questions have been answered in the context of prospective randomized trials. Important considerations for MIS and cancer have been addressed, such as what are the important immunologic consequences of MIS versus open surgery and what is the role of laparoscopy in the staging of gastrointestinal cancers? This review article discusses many of the key controversies in the minimally invasive treatment of cancer using the pro-con debate format.
authors: Beth Israel Deaconess Medical Center, Boston, MA, USA.
authors: Melanie
authors: M
authors: Goldfarb
authors: Steven
authors: S
authors: Brower
authors: S D
authors: SD
authors: Schwaitzberg
mesh_terms: D000818:Animals; D003131:Combined Modality Therapy; D016207:Cytokines / Q000378:metabolism; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D016629:Esophagectomy / Q000379:methods; D006801:Humans; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D007249:Inflammation; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism; D010535:Laparoscopy / Q000009:adverse effects / Q000379:methods; D007813:Laparotomy / Q000009:adverse effects / Q000379:methods; D007902:Length of Stay; D008197:Lymph Node Excision / Q000379:methods; D019060:Minimally Invasive Surgical Procedures / Q000009:adverse effects; D009369:Neoplasms / Q000276:immunology / Q000601:surgery*; D018579:Patient Selection; D011028:Pneumoperitoneum, Artificial / Q000009:adverse effects; D011183:Postoperative Complications / Q000209:etiology / Q000276:immunology; D016032:Randomized Controlled Trials as Topic; D013274:Stomach Neoplasms / Q000601:surgery; D034421:Sus scrofa
chemical_list: D016207:Cytokines; D036341:Intercellular Signaling Peptides and Proteins